New York State Common Retirement Fund’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $111K | Hold |
8,497
| – | – | ﹤0.01% | 2514 |
|
2025
Q1 | $90K | Sell |
8,497
-1,100
| -11% | -$11.7K | ﹤0.01% | 2562 |
|
2024
Q4 | $163K | Hold |
9,597
| – | – | ﹤0.01% | 2390 |
|
2024
Q3 | $223K | Hold |
9,597
| – | – | ﹤0.01% | 2238 |
|
2024
Q2 | $234K | Buy |
9,597
+20
| +0.2% | +$488 | ﹤0.01% | 2359 |
|
2024
Q1 | $323K | Sell |
9,577
-27
| -0.3% | -$911 | ﹤0.01% | 2251 |
|
2023
Q4 | $303K | Sell |
9,604
-42
| -0.4% | -$1.33K | ﹤0.01% | 2281 |
|
2023
Q3 | $246K | Buy |
9,646
+72
| +0.8% | +$1.84K | ﹤0.01% | 2333 |
|
2023
Q2 | $275K | Sell |
9,574
-5,726
| -37% | -$164K | ﹤0.01% | 2359 |
|
2023
Q1 | $367K | Hold |
15,300
| – | – | ﹤0.01% | 2332 |
|
2022
Q4 | $259K | Sell |
15,300
-9
| -0.1% | -$152 | ﹤0.01% | 2614 |
|
2022
Q3 | $227K | Buy |
15,309
+49
| +0.3% | +$727 | ﹤0.01% | 2719 |
|
2022
Q2 | $240K | Sell |
15,260
-14
| -0.1% | -$220 | ﹤0.01% | 2711 |
|
2022
Q1 | $412K | Sell |
15,274
-5
| -0% | -$135 | ﹤0.01% | 2492 |
|
2021
Q4 | $565K | Sell |
15,279
-35
| -0.2% | -$1.29K | ﹤0.01% | 2373 |
|
2021
Q3 | $732K | Sell |
15,314
-2,554
| -14% | -$122K | ﹤0.01% | 2255 |
|
2021
Q2 | $605K | Sell |
17,868
-932
| -5% | -$31.6K | ﹤0.01% | 2493 |
|
2021
Q1 | $776K | Sell |
18,800
-1,100
| -6% | -$45.4K | ﹤0.01% | 2240 |
|
2020
Q4 | $863K | Buy |
19,900
+7,900
| +66% | +$343K | ﹤0.01% | 2101 |
|
2020
Q3 | $515K | Hold |
12,000
| – | – | ﹤0.01% | 2194 |
|
2020
Q2 | $561K | Buy |
+12,000
| New | +$561K | ﹤0.01% | 2146 |
|